Macquarie Group LTD Medtronic PLC Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Medtronic PLC stock. As of the latest transaction made, Macquarie Group LTD holds 156,790 shares of MDT stock, worth $12.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

156,790

Previous 150,263 4.34%

Holding current value

$12.8 Million

Previous $11.8 Million 19.35%

% of portfolio

0.02%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$76.84 - $91.03 $501,534 - $594,152	6,527 Added 4.34%	156,790 $14.1 Million
Q2 2024 Aug 09, 2024	SELL	$78.71 - $87.02 $2.47 Million - $2.73 Million	-31,328 Reduced 17.25%	150,263 $11.8 Million
Q1 2024 May 14, 2024	SELL	$82.84 - $88.09 $2.82 Million - $3 Million	-34,092 Reduced 15.81%	181,591 $15.8 Million
Q4 2023 Feb 14, 2024	SELL	$69.43 - $83.43 $536,971 - $645,247	-7,734 Reduced 3.46%	215,683 $17.8 Million
Q3 2023 Nov 14, 2023	SELL	$78.22 - $90.4 $1.52 Million - $1.76 Million	-19,447 Reduced 8.01%	223,417 $17.5 Million
Q2 2023 Aug 14, 2023	SELL	$79.47 - $91.38 $2.03 Million - $2.34 Million	-25,555 Reduced 9.52%	242,864 $21.4 Million
Q1 2023 May 15, 2023	SELL	$76.72 - $87.58 $355,750 - $406,108	-4,637 Reduced 1.7%	268,419 $21.6 Million
Q4 2022 Feb 21, 2023	BUY	$76.18 - $87.74 $414,647 - $477,568	5,443 Added 2.03%	273,056 $21.2 Million
Q3 2022 Nov 14, 2022	SELL	$80.75 - $95.31 $2.43 Million - $2.87 Million	-30,149 Reduced 10.13%	267,613 $21.6 Million
Q2 2022 Aug 15, 2022	SELL	$87.4 - $113.09 $16.4 Million - $21.3 Million	-187,986 Reduced 38.7%	297,762 $26.7 Million
Q1 2022 May 16, 2022	SELL	$100.58 - $112.38 $2.68 Million - $3 Million	-26,679 Reduced 5.21%	485,748 $53.9 Million
Q4 2021 Feb 11, 2022	BUY	$99.53 - $127.75 $2.94 Million - $3.77 Million	29,541 Added 6.12%	512,427 $53 Million
Q3 2021 Nov 12, 2021	SELL	$122.75 - $135.17 $1,964 - $2,162	-16 Reduced -0.0%	482,886 $60.5 Million
Q2 2021 Aug 13, 2021	BUY	$118.19 - $131.5 $3.53 Million - $3.93 Million	29,876 Added 6.59%	482,902 $59.9 Million
Q1 2021 May 14, 2021	SELL	$111.18 - $119.74 $7.27 Million - $7.83 Million	-65,362 Reduced 12.61%	453,026 $53.5 Million
Q4 2020 Feb 16, 2021	SELL	$100.57 - $117.14 $1.55 Million - $1.8 Million	-15,379 Reduced 2.88%	518,388 $60.7 Million
Q3 2020 Nov 13, 2020	BUY	$90.13 - $108.78 $1.12 Million - $1.35 Million	12,402 Added 2.38%	533,767 $55.5 Million
Q2 2020 Aug 11, 2020	SELL	$84.11 - $103.33 $900,565 - $1.11 Million	-10,707 Reduced 2.01%	521,365 $47.8 Million
Q1 2020 May 15, 2020	SELL	$72.92 - $121.3 $4.26 Million - $7.09 Million	-58,479 Reduced 9.9%	532,072 $48 Million
Q4 2019 Feb 14, 2020	BUY	$104.49 - $114.54 $14.1 Million - $15.4 Million	134,602 Added 29.52%	590,551 $67 Million
Q3 2019 Nov 14, 2019	SELL	$98.02 - $111.18 $271,123 - $307,523	-2,766 Reduced 0.6%	455,949 $49.5 Million
Q2 2019 Aug 14, 2019	BUY	$84.15 - $99.38 $2.22 Million - $2.63 Million	26,424 Added 6.11%	458,715 $44.7 Million
Q1 2019 May 15, 2019	BUY	$82.45 - $93.79 $3.71 Million - $4.22 Million	44,942 Added 11.6%	432,291 $39.4 Million
Q4 2018 Feb 15, 2019	BUY	$85.8 - $99.49 $4.15 Million - $4.81 Million	48,321 Added 14.25%	387,349 $35.2 Million
Q3 2018 Nov 15, 2018	SELL	$85.91 - $99.17 $17,182 - $19,834	-200 Reduced 0.06%	339,028 $33.4 Million
Q2 2018 Aug 14, 2018	BUY	$77.48 - $87.83 $196,876 - $223,176	2,541 Added 0.75%	339,228 $29 Million
Q1 2018 May 11, 2018	BUY	$76.55 - $87.26 $172,696 - $196,858	2,256 Added 0.67%	336,687 $27 Million
Q4 2017 Feb 15, 2018	SELL	$76.93 - $83.5 $6.97 Million - $7.56 Million	-90,564 Reduced 21.31%	334,431 $27.2 Million
Q3 2017 Nov 08, 2017	BUY	$77.71 - $84.6 $33 Million - $36 Million	424,995	424,995 $33.1 Million

Others Institutions Holding MDT

# of Institutions

2,289

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Medtronic PLC Transaction History